The U.S. is in a dire situation. For years we’ve been over-dependent on China for rare earth supply. However, that arrangement isn’t reliable, nor is it safe — forcing us to look elsewhere. Making the situation far worse, China has threatened to withhold rare earth AGAIN, well aware that if they choke supply, they rattle … Continue reading This is Why the U.S. in on the Hunt for Rare Earth
The world could soon run into a massive lithium supply crunch. All thanks to the electric vehicle boom that shows no signs of slowing down. In fact, we can see just how enthused EV investors have become by looking at stocks, like Tesla and Nio. While the pandemic has slowed growth, EV demand is only … Continue reading The Top Reasons the World Must Have More Lithium Supply
Over the last few months, shares of NIO raced from a low of $3.18 to $27.40 a share. With solid monthly growth and earnings, coupled with higher demand for electric vehicles, NIO could see higher highs. For September, Nio delivered 4,708 vehicles, growth of 133% year over year. And it announced it delivered 12,206 vehicles … Continue reading This is Why Shares of Nio Inc. are Racing Higher
The vegan boom has revolutionized the health and wellness market. So much so that the global vegan cosmetics market could be worth up to $20.8 billion over the next five years, according to Grand View Research. “Consumers are shifting their preference from chemical-based beauty products, owing to safety reasons, and are drawn towards ‘natural’ and … Continue reading Vegan Boom Revolutionizing $4.2 Trillion Health and Wellness Market
The electric vehicle boom is already here. By 2025, EVs could account for a third of all auto sales. By 2030, EVs could surpass internal combustion engine vehicles with a market share of 51%, according to a new study from the Boston Consulting Group. Some analysts note global production of EVs could top four million, … Continue reading The Newest EV Maker Planning to File for U.S. Listing
We’re in desperate need for a COVID-19 vaccine. Months into the global pandemic, the virus has infected just over 11 million people worldwide, killing more than 530,000. U.S. states are backtracking on reopening plans as cases rise. Hospitals are being overwhelmed. There’s even fear global economies may need to be shut down again. it’s why … Continue reading Novavax Soars on $1.6 Billion Operation Warp Speed Award
The Fed is coming to the rescue again. In fact, it just announced it will now buy individual corporate bonds, on tops of the exchange-traded funds it’s been buying. The program has the ability to buy up to $750 billion worth of corporate credit. “The decision to buy a broad portfolio of corporate bonds represents … Continue reading Federal Reserve to Buy Corporate Bonds for the First Time
The psychedelics boom may be even more profitable than cannabis. Granted, such drugs have been written off for years. But that may not be the case for much longer. With many like LSD, MDMA, and psilocybin showing promise for treating a range of mental and health conditions, including obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating … Continue reading The Psychedelic Boom Could be Bigger than Cannabis
The U.S. again blamed China for its lack of transparency over the coronavirus. China then suggested the U.S. might be the real source of the pandemic. China has also said the U.S. is trying to shift blamed for the U.S. mishandling of the COVID-19 crisis, says Reuters. On top of that, the U.S. just passed … Continue reading This Could Lead to Another Disastrous Trade War
Aurora Cannabis is rocketing this morning on news it struck a deal to enter the U.S. cannabis market after buying CBD company, Reliva. “It’s immediate access into the world’s largest cannabinoid market,” Aurora Executive Chairman and interim CEO Michael Singer, as quoted by CNBC. “I think the Reliva acquisition is a responsible strategic entry into the … Continue reading Aurora Cannabis Rockets on CBD deal to enter the U.S. market
